[PDF][PDF] Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe
MR Sharland, C Pulcini, S Harbarth… - Lancet Infectious …, 2018 - openaccess.sgul.ac.uk
Background Optimising the use of antimicrobials is a key priority of the global strategy to
combat antimicrobial resistance (AMR). 1 Antibiotic guidance should be developed to meet …
combat antimicrobial resistance (AMR). 1 Antibiotic guidance should be developed to meet …
Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool
Comment www. thelancet. com/infection Vol 19 December 2019 1279 of activity, and
potential for inducing antimicrobial resistance, whereas Reserve antibiotics were selected …
potential for inducing antimicrobial resistance, whereas Reserve antibiotics were selected …
The WHO AWaRe Antibiotic Book: providing guidance on optimal use and informing policy
M Sharland, B Cappello, LA Ombajo… - The Lancet Infectious …, 2022 - thelancet.com
Comment www. thelancet. com/infection Vol 22 November 2022 1529 stewardship,
particularly optimising the use of Access antibiotics and short durations when appropriate …
particularly optimising the use of Access antibiotics and short durations when appropriate …
The crisis of no new antibiotics—what is the way forward?
LJV Piddock - The Lancet infectious diseases, 2012 - thelancet.com
Antibiotic use not only underpins modern medicine, but has brought huge changes to the
world, especially in expectations of survival of children into adulthood. The theme of World …
world, especially in expectations of survival of children into adulthood. The theme of World …
Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross …
I Adekoya, D Maraj, L Steiner, H Yaphe… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background The WHO Model List of Essential Medicines classified antibiotics into
Access, Watch, and Reserve (AWaRe) categories for the treatment of 31 priority bacterial …
Access, Watch, and Reserve (AWaRe) categories for the treatment of 31 priority bacterial …
A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail
DA Goff, R Kullar, EJC Goldstein, M Gilchrist… - The Lancet Infectious …, 2017 - thelancet.com
In February, 2016, WHO released a report for the development of national action plans to
address the threat of antibiotic resistance, the catastrophic consequences of inaction, and …
address the threat of antibiotic resistance, the catastrophic consequences of inaction, and …
Global increases in antibiotic consumption: a concerning trend for WHO targets
SC Roberts, TR Zembower - The Lancet Infectious Diseases, 2021 - thelancet.com
Worldwide, antimicrobial resistance is increasing at an alarming rate. In 2019, WHO listed
antimicrobial resistance as one of the top ten threats to global health. 1 A major driver of …
antimicrobial resistance as one of the top ten threats to global health. 1 A major driver of …
UN High-Level Meeting on antimicrobials—what do we need?
R Laxminarayan, CF Amábile-Cuevas, O Cars, T Evans… - The Lancet, 2016 - thelancet.com
Global access to effective antimicrobials is under threat. 1 Over 700 000 deaths worldwide,
including 214 000 neonatal sepsis deaths, are attributable to resistant bacterial pathogens …
including 214 000 neonatal sepsis deaths, are attributable to resistant bacterial pathogens …
Antibiotic resistance: global response needed
SJ Howard, M Catchpole, J Watson… - The Lancet Infectious …, 2013 - thelancet.com
In 1945, Sir Alexander Fleming famously warned of the danger of over-reliance on
antibiotics and the threat of bacteria developing resistance. 1 68 years later, his prediction …
antibiotics and the threat of bacteria developing resistance. 1 68 years later, his prediction …
A comprehensive regulatory framework to address the unmet need for new antibacterial treatments
JH Rex, BI Eisenstein, J Alder… - The Lancet Infectious …, 2013 - thelancet.com
To bring new antibacterial drugs to the market is challenging because discovery of new
agents is difficult, two large trials per indication are needed in accordance with traditional …
agents is difficult, two large trials per indication are needed in accordance with traditional …